If you cannot view the webinar on ON24, please use this link.
Join us for this webinar, where you will:
- Understand the principles and technical considerations of SBRT for pancreatic cancer treatment, including patient selection criteria, dose prescription, image guidance, and treatment planning techniques/platforms.
- Identify the potential benefits and limitations of SBRT in the management of pancreatic cancer, including its impact on tumor control, toxicity profiles, and patient outcomes compared to conventional radiation therapy approaches.
- Gain proficiency in contouring and delineating target volumes and critical structures specific to SBRT for pancreatic cancer treatment
- Develop strategies for multidisciplinary collaboration among radiation oncologists, physicists, and radiation therapists to optimize patient care pathways and ensure safe and effective delivery of SBRT for pancreatic cancer.
Presenter: Matthew Abrams, M.D.
Radiation Oncologist, Beth Israel Deaconess Medical Center, Boston, MA, USA
Matthew Abrams, M.D., is the lead Radiation Oncologist for Gastrointestinal Malignancies at Beth Israel Deaconess Medical Center in Boston, Massachusetts. He is also an Assistant Professor of Radiation Oncology at Harvard Medical School.
Moderator: Anand Mahadevan, M.D., FRCS, FRCR
Radiation Oncologist, Professor of Radiation Oncology, Perlmutter Cancer Center at NYU Langone Health, New York, USA
Dr. Anand Mahadevan is Professor of Radiation Oncology at NYU Langone. Before this, Dr. Mahadevan was Professor and Chairman of the Department of Radiation Oncology at Geisinger Cancer Institute – Geisinger Health, Geisinger Commonwealth School of Medicine, in Danville, Pennsylvania. Dr. Mahadevan is the Chairperson of the RSSearch® Patient Registry Committee.
He completed his general surgical and oncology residency in the United Kingdom and completed his fellowship at Beth Israel Deaconess Medical Center (BIDMC) in the Joint Center Harvard Radiation Oncology Program. He was then in the faculty of the Harvard Radiation Oncology Program until 2016.
Dr. Mahadevan’s area of focus is Stereotactic Radiosurgery and SBRT for liver/pancreas tumors and oligometastases.
